These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21085663)

  • 21. Oligomer-targeting with a conformational antibody fragment promotes toxicity in Aβ-expressing flies.
    Wacker J; Rönicke R; Westermann M; Wulff M; Reymann KG; Dobson CM; Horn U; Crowther DC; Luheshi LM; Fändrich M
    Acta Neuropathol Commun; 2014 Apr; 2():43. PubMed ID: 24725347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and characterization of a monoclonal antibody with high affinity for soluble Abeta oligomers.
    Ying Z; Xin W; Jin-Sheng H; Fu-Xiang B; Wei-Min S; Xin-Xian D; Xiao-Bo W; Yi-Qin L; Xian-Xian Z; Hong-Gang H; Xiang-Lei P; Yan-Peng Z; Ling-Ling H; Tao H
    Hybridoma (Larchmt); 2009 Oct; 28(5):349-54. PubMed ID: 19857116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
    Izzo NJ; Xu J; Zeng C; Kirk MJ; Mozzoni K; Silky C; Rehak C; Yurko R; Look G; Rishton G; Safferstein H; Cruchaga C; Goate A; Cahill MA; Arancio O; Mach RH; Craven R; Head E; LeVine H; Spires-Jones TL; Catalano SM
    PLoS One; 2014; 9(11):e111899. PubMed ID: 25390692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies against large oval aggregates of Aβ1-42.
    Shimizu T; Yoshimune K; Komoriya T; Akiyama T; Ye X; Kohno H
    J Biosci Bioeng; 2013 Feb; 115(2):216-20. PubMed ID: 23041139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of a low pH antigen-antibody dissociation procedure for ELISA measurement of circulating anti-Abeta antibodies.
    Li Q; Gordon M; Cao C; Ugen KE; Morgan D
    BMC Neurosci; 2007 Mar; 8():22. PubMed ID: 17374155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenic properties of amyloid beta oligomers.
    Dalgediene I; Lasickiene R; Budvytyte R; Valincius G; Morkuniene R; Borutaite V; Zvirbliene A
    J Biomed Sci; 2013 Feb; 20(1):10. PubMed ID: 23432787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice.
    Wang HC; Yu YZ; Liu S; Zhao M; Xu Q
    Vaccine; 2016 Apr; 34(15):1758-66. PubMed ID: 26945100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformation-dependent single-chain variable fragment antibodies specifically recognize beta-amyloid oligomers.
    Wang XP; Zhang JH; Wang YJ; Feng Y; Zhang X; Sun XX; Li JL; Du XT; Lambert MP; Yang SG; Zhao M; Klein WL; Liu RT
    FEBS Lett; 2009 Feb; 583(3):579-84. PubMed ID: 19162022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular interactions between monoclonal oligomer-specific antibody 5E3 and its amyloid beta cognates.
    Khorvash M; Blinov N; Ladner-Keay C; Lu J; Silverman JM; Gibbs E; Wang YT; Kovalenko A; Wishart D; Cashman NR
    PLoS One; 2020; 15(5):e0232266. PubMed ID: 32469918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation and Partial Characterization of Rabbit Monoclonal Antibody to Pyroglutamate Amyloid-β3-42 (pE3-Aβ).
    Mehta PD; Patrick BA; Barshatzky M; Mehta SP; Frackowiak J; Mazur-Kolecka B; Wegiel J; Wisniewski T; Miller DL
    J Alzheimers Dis; 2018; 62(4):1635-1649. PubMed ID: 29504532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice.
    Mably AJ; Liu W; Mc Donald JM; Dodart JC; Bard F; Lemere CA; O'Nuallain B; Walsh DM
    Neurobiol Dis; 2015 Oct; 82():372-384. PubMed ID: 26215784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
    Guivernau B; Bonet J; Valls-Comamala V; Bosch-Morató M; Godoy JA; Inestrosa NC; Perálvarez-Marín A; Fernández-Busquets X; Andreu D; Oliva B; Muñoz FJ
    J Neurosci; 2016 Nov; 36(46):11693-11703. PubMed ID: 27852777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies.
    Lambert MP; Viola KL; Chromy BA; Chang L; Morgan TE; Yu J; Venton DL; Krafft GA; Finch CE; Klein WL
    J Neurochem; 2001 Nov; 79(3):595-605. PubMed ID: 11701763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synaptic targeting by Alzheimer's-related amyloid beta oligomers.
    Lacor PN; Buniel MC; Chang L; Fernandez SJ; Gong Y; Viola KL; Lambert MP; Velasco PT; Bigio EH; Finch CE; Krafft GA; Klein WL
    J Neurosci; 2004 Nov; 24(45):10191-200. PubMed ID: 15537891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of β-amyloid oligomer recognition with a conformational antibody fragment.
    Morgado I; Wieligmann K; Bereza M; Rönicke R; Meinhardt K; Annamalai K; Baumann M; Wacker J; Hortschansky P; Malešević M; Parthier C; Mawrin C; Schiene-Fischer C; Reymann KG; Stubbs MT; Balbach J; Görlach M; Horn U; Fändrich M
    Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12503-8. PubMed ID: 22814377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibody-catalyzed hydrolysis of amyloid beta peptide.
    Taguchi H; Planque S; Nishiyama Y; Symersky J; Boivin S; Szabo P; Friedland RP; Ramsland PA; Edmundson AB; Weksler ME; Paul S
    J Biol Chem; 2008 Feb; 283(8):4714-22. PubMed ID: 18086674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A coiled conformation of amyloid-β recognized by antibody C706.
    Teplyakov A; Obmolova G; Gilliland GL
    Alzheimers Res Ther; 2017 Aug; 9(1):66. PubMed ID: 28830506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic dimeric Aβ(28-40) mimics the complex epitope of human anti-Aβ autoantibodies against toxic Aβ oligomers.
    Roeder AM; Roettger Y; Stündel A; Dodel R; Geyer A
    J Biol Chem; 2013 Sep; 288(38):27638-27645. PubMed ID: 23846683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.